Home About Us Contact Us

 

Table of Content - Volume 10 Issue 1 - April 2018


 

Assessment of lung function and diffusion capacity among cases with and without microvascular complications of diabetes mellitus - A cross sectional study

 

Karthikeyan Ganesan1, Karthikeyan Navaneetham2*

 

1,2Assistant professor, Department of General Medicine, Thiruvarur Medical College, Thiruvarur, Tamil Nadu, INDIA.

Email: kartheeg@yahoo.co.in karthiknavneeth@gmail.com

 

REFERENCES

  1. Jameson JL, de Kretser DM, Marshall JC, De Groot LJ. Endocrinology Adult and Pediatric: Reproductive Endocrinology. Elsevier Health Sciences; 2013 May 7.
  2. Idf.org. (2019). Members. [online] Available at: https://www.idf.org/our-network/regions-members/south-east-asia/members/94-india.html [Accessed 25 Mar. 2019].
  3. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clinical diabetes. 2008 Apr 1; 26(2):77-82.
  4. Ljubic S, Metelko Z, Car N, Roglic G, Drazic Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998; 114: 1033-5.
  5. Marvisi M, Bartolini L, del Borrello P, Brianti M, Marani G, Guariglia A, et al. Pulmonary function in non-insulindependent diabetes mellitus. Respiration 2001; 68:268-272.
  6. Sinha S, Guleria R, Misra A, Pandey RM, Yadav R, Tiwari S. Pulmonary functions in patients with type 2 diabetes mellitus and correlation with anthropometry and microvascular complications. Indian J Med Res 2004; 119: 66-71.
  7. Guvener N, Tutuncu NB, Akcay S, Eyuboglu F, Gokcel A. Alveolar gas exchange in pati-ents with type 2 diabetes mellitus. Endocrin J 2003; 50: 663-7.
  8. Lau AC, Lo MK, Leung GT, Choi FP, Yam LY, Wasserman K. Altered exercise gas exchange as related to microalbuminuria in type 2 diabetic patients. Chest 2004;125: 1292-8.
  9. Isotani H, Nakamura Y, Kameoka K, Tanaka K, Furukawa K, Kitaoka H, et al. Pulmonary diffusing capacity, serum angiotensin-converting enzyme activity and the angiotensin-converting enzyme gene in Japanese non-insulin dependent diabetes mellitus patients. Diabetes Res ClinPract1999; 43: 173-7.
  10. Dalquen P. The lung in diabetes mellitus. Respiration 1999; 66: 12-3.
  11. American Diabetes Association: Standards of medical care in diabetes—2007 [Position Statement]. Diabetes Care 30:S4–S41, 2007
  12. American Thoracic Society; American College of Chest Physicians, ATS/ACCP statement on cardiopulmonary exercise testing, Am. J. Respir. Crit. Care Med. 167 (2003) 211–277.
  13. Mori H, Okubo M, Okamura M, Yamane K, Kado S, Egusa G, Hiramoto T, Hara H, Yamakido M. Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus. Internal medicine. 1992; 31(2):189-93.
  14. Agarwal AS, Fuladi AB, Mishra G, Tayade BO. Spirometry and diffusion studies in patients with type-2 diabetes mellitus and their association with microvascular complications. The Indian journal of chest diseases and allied sciences. 2010 Oct; 52(4):213.
  15. Innocenti F, Fabbri A, Anichini R, Tuci S, Pettina G, Vannucci F, De Giorgio LA, Seghieri G. Indications of reduced pulmonary function in type 1 (insulin-dependent) diabetes mellitus. Diabetes research and clinical practice. 1994 Oct 1; 25(3):161-8.
  16. Davis WA, Knuiman M, Kendall P, Grange V, Davis TM. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes care. 2004 Mar 1; 27(3):752-7.
  17. Çelik P, Ozmen B, YorgancVoglu A, Ozmen D, Çok G. Pulmonary function parameters in patients with diabetes mellitus. Turk J EndocrMetab. 1999; 1:5-10.